Tilray Brands (TLRY) Net Cash Flow Growth (3y) (2022 - 2026)
Tilray Brands (TLRY) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -62.71% |
| 10 | Tilray Brands | 456.90 Mn | 396.70 Mn | 54.95 Mn | 27.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 27.49% |
| Nov 30, 2025 | 60.51% |
| Aug 31, 2025 | -17.24% |
| May 31, 2025 | -49.70% |
| Feb 28, 2025 | 30.65% |
| Nov 30, 2024 | 33.04% |
| Aug 31, 2024 | 39.68% |
| May 31, 2024 | -34.48% |
| Nov 30, 2023 | 42.39% |
| Aug 31, 2023 | 23.61% |
| May 31, 2023 | -50.44% |
| May 31, 2022 | -20.45% |